An analysis of mortality and body mass index (BMI) data from 1971 through 2000 revealed that while being either underweight (BMI 18.5 or less) or obese (BMI 30 to 35 or greater) could endanger your life, just being overweight (BMI 25 to less than 30) did not. On the contrary, it turned out that overweight people had lower mortality rates from any cause than people who managed to maintain a so-called normal weight (BMI 18.5 to less than 25).
An analysis of mortality and body mass index (BMI) data from 1971 through 2000 revealed that while being either underweight (BMI 18.5 or less) or obese (BMI 30 to 35 or greater) could endanger your life, just being overweight (BMI 25 to less than 30) did not. On the contrary, it turned out that overweight people had lower mortality rates from any cause than people who managed to maintain a so-called normal weight (BMI 18.5 to less than 25).1
Now a refined analysis of the data enables the same researchers to be more specific about the advantages-and risks-of being overweight.2 In the new study, researchers examined cause-specific excess deaths in the year 2004 from cardiovascular disease (CVD), cancer, and all other causes, and correlated these with BMI categories. The analysis showed that
Where does all this leave the primary care practitioner, puzzling over what advice to give patients about maintaining a healthy weight? Clearly, obese patients should be counseled to lose weight, and underweight patients to try to put on a few pounds. And as for your "overweight" patients? Perhaps it's time to revise that definition.
1. Flegal KM, Graubard BI, Williamson DF, et al. Excess deaths associated with underweight, overweight, and obesity.JAMA. 2005;293(15):1861-1867.
2. Flegal KM, Graubard BL, Williamson DF, et al. Cause-specific excess deaths associated with underweight, overweight, and obesity. JAMA. 2007; 298(17):2028-2037.
Study Highlights Critical Need For Improved Understanding of Childhood Interstitial Lung Disease
December 10th 2024Diagnostic criteria for pulmonary fibrosis and other fibrotic diseases in children are lacking. That void hampers an understanding of how disease progresses in children and adolescents and what the outcomes are.
Read More
Breaking Down Health Plans, HSAs, AI With Paul Fronstin of EBRI
November 19th 2024Featured in this latest episode of Tuning In to the C-Suite podcast is Paul Fronstin, director of health benefits research at EBRI, who shed light on the evolving landscape of health benefits with editors of Managed Healthcare Executive.
Listen
More Than 400 Plastic Chemicals Could Be Linked to Breast Cancer
December 10th 2024Researchers have compiled a list of chemicals commonly found in plastics, including benzophenones, chlorinated paraffins and PFAS, known as “forever chemicals,” and they say there might be a connection to breast cancer.
Read More
In this latest episode of Tuning In to the C-Suite podcast, Briana Contreras, an editor with MHE had the pleasure of meeting Loren McCaghy, director of consulting, health and consumer engagement and product insight at Accenture, to discuss the organization's latest report on U.S. consumers switching healthcare providers and insurance payers.
Listen